This article critically reviews both established and experimental treatment modalities for
anogenital (AG) warts. Efficacy, cost, safety, advantages and disadvantages of each therapy …

Anogenital warts (AGWs) are an important issue for public health centers dealing with
Sexually Transmitted Infections. They are epidemiologically relevant, with significant …

Background Anogenital warts (AGW) can cause economic burden on healthcare systems
and are associated with emotional, psychological and physical issues. Objective To provide …

Background Although new HPV vaccines have been developed and are in the process of
implementation, anogenital warts remain a very frequent problem in clinical practice …

This article discusses the prevalence, clinical presentation and treatment of anogenital
warts. These warts refer to the pedunculated, papular or macular lesions of the anal and/or …

The risk of acquiring genital papillomavirus infection (GPVI) is covariant with early sexual
debut, frequent partner changes, concurrent and previous other sexually transmitted …

Anogenital warts (AGWs) are the most prevalent sexually transmitted viral infections in the
United States of America. Symptomatic warts can be seen in nearly 1% of the population …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

There is a series of different therapies for the treatment of anogenital warts. Home therapy
should be reserved only for initial therapy of simple cases. Such approaches include …

Anogenital warts (AGWs) are a very common disease. They are caused mostly by low-risk
human papillomaviruses (HPV) 6 and 11, particularly the former. Clinical presentation is …